(Q34281886)

1 August 2017

1 reference

title

Palliative radiotherapy regimens for non-small cell lung cancer. (English)

1 reference

1 August 2017

Palliative radiotherapy regimens for non-small cell lung cancer (English)

0 references

1 reference

B Coles

3

0 references

author name string

F Macbeth

1

1 reference

1 August 2017

E Toy

2

1 reference

1 August 2017

A Melville

4

1 reference

1 August 2017

A Eastwood

5

1 reference

1 August 2017

B Coles

3

0 references

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Cochrane Database of Systematic Reviews

1 August 2017

2001

0 references

published in

1 reference

1 August 2017

CD002143

1 reference

1 August 2017

2

1 reference

Palliative radiation for stage 3 non-small cell lung cancer--a prospective study of two moderately high dose regimens

1 August 2017

3

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

Palliative radiotherapy for lung cancer: two versus five fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

Hypofractionated irradiation for inoperable non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

Immediate side effects of large fraction radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

Assessment of quality of life in small-cell lung cancer using a Daily Diary Card developed by the Medical Research Council Lung Cancer Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

The linear-quadratic formula and progress in fractionated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

Approaches to the analysis of quality of life data: experiences gained from a medical research council lung cancer working party palliative chemotherapy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

Radiation myelopathy: estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer. The Medical Research Council Lung Cancer Working Party.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

Audit: the use of radiotherapy for NSCLC in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

Measuring quality of life in oncology: is it worthwhile? II. Experiences from the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

Invited review: permanent radiation myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

Radiobiological prediction of normal tissue toxicities and tumour response in the radiotherapy of advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Wor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60 GY: results of a randomized equivalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

[Radiotherapy for stage III, inoperable, asymptomatic small cell lung cancer. Final results of a prospective randomized study (240 patients)]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

A randomized study on palliative radiation therapy for inoperable non small cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

Prospective evaluation of a watch policy in patients with inoperable non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

A case of radiation myelopathy after 2 x 8.5 Gy for inoperable non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

Loss of local control with prolongation in radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

Acute changes in peak expiratory flow rate following palliative radiotherapy for bronchial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

The impact of overall treatment time on the results of radiotherapy for nonsmall cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

The use of discriminant analysis to guide palliative treatment for lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002143

10.1002/14651858.CD002143

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference